Significant variability in response to inhaled corticosteroids for persistent asthma. - Wikidata - awgldk - TriplyDB

Significant variability in response to inhaled corticosteroids for persistent asthma.

Significant variability in response to inhaled corticosteroids for persistent asthma.

http://www.wikidata.org/entity/Q43920193

about

Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma Clinical asthma phenotypes in the real world: opportunities and challenges New combination treatments in the management of asthma: focus on fluticasone/vilanterol Identification of innate immune response endotypes in asthma: implications for personalized medicine Key observations from the NHLBI Asthma Clinical Research Network Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations HLA-DQ strikes again: genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults.Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.Asthma outcomes: exacerbations Asthma outcomes: biomarkers Predicting intermediate phenotypes in asthma using bronchoalveolar lavage-derived cytokines.Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide.Immunoglobulin E-mediated airway inflammation is active in most patients with asthma.Monitoring asthma control using claims data and patient-reported outcomes measures The Saudi Initiative for Asthma.The role of pharmacogenomics in improving the management of asthma Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma.Categorizing asthma severity: an overview of national guidelines.Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study Outcome of occupational asthma after removal from exposure: A follow-up study.Vitamin D levels, lung function, and steroid response in adult asthma.The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial.Lessons learned from variation in response to therapy in clinical trials.Chronic inflammation and asthma.In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma.Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients Classifying asthma severity and treatment determinants: national guidelines revisited.Repeatability of response to asthma medications.Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma.Pharmacogenomics of pediatric asthma.Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial.The role of inhaled and/or nasal corticosteroids on the bronchodilator response Patterns of inhaled corticosteroid use and asthma control in the Childhood Asthma Management Program Continuation Study.

P2860

Q24243570-2F8E21FA-1E27-470C-BAED-CFB5D6EB44E9 Q24246921-F1C7CFD3-E851-4CEB-80B5-C7221EA0560F Q24247765-9FED452E-5E65-472A-B7C9-E5D13CD73247 Q24558608-02005024-141C-431C-89FB-6757FA780FFF Q24614404-6DE991F4-D7E5-40DC-853F-2176D5840D18 Q26771615-D48982B8-9778-4C59-96A5-19E729DC3133 Q26772201-E7B0C658-7821-4929-813C-1326B9BD3884 Q26775236-63C1DB70-0F9A-4ACC-8BEB-B7252CEBDDDD Q26852898-B7E53726-F4DA-48BE-BCF6-392E34642742 Q26860910-7B2744A9-6E27-45D6-97AC-25E13381A5CC Q27025957-B97596BD-D77E-4D42-9A10-AEC5DE55539D Q28392274-7958A9C9-5B38-4A45-86D7-6B385957EA64 Q29417102-4BC5E76A-5B5C-4FA2-8F22-87FEBCF68902 Q30417919-FFB4169C-F0D9-4EF4-A09A-12F4CE7EB55E Q30421935-22B2F440-F659-4CE4-8949-32E563313C70 Q30425168-07513705-889F-4914-9271-8965F8325F69 Q30433497-6752A10C-8FF3-4D30-B25A-6B9EE18E23B0 Q30436056-4F829A36-383E-4013-9C53-6881223F4E77 Q30444397-98702A58-8C7F-4BB3-BB45-E0FC9059C22A Q33502728-6BD10FF5-EC12-4B4F-A6BD-356CE3388280 Q33568644-9265386B-E30B-4393-B0FF-348FEF4931A3 Q33669054-E8725C61-EC60-4588-B5EF-CC83E0E25EE7 Q33693320-71AFBD58-CAC7-4B73-A31B-CEDBA90214E2 Q33723527-3B709001-3830-47A3-B199-0E7B0025889F Q33755127-0722259B-5D2E-4062-9E67-40606A4A7D7A Q33836175-999ABD14-69CF-40B4-A8E9-B93843676E60 Q33845615-4F7C2F7E-CC33-4FE3-B128-D82DE2C7AB05 Q33858088-D21EDB06-37A2-4758-8B6E-B7EBBFF9A55C Q33999050-BA30AD7F-13DC-45A9-9B95-815A8F9B1F97 Q34073570-18998E29-D8BD-4210-B8BE-A03766AFFF74 Q34120964-AF351FB0-6304-4700-9BCE-5D162A40DBFE Q34143925-0BE9DD10-E20A-422C-B47A-D9AC3F553C17 Q34220633-A1A01214-29B4-4AC8-B392-F4A6A2456FC5 Q34307611-DF81B2FA-FA45-4D68-9CEE-BDD270F7DFC8 Q34318910-CC9D1C23-9A7A-4949-A1EE-39814FE9CD6C Q34388432-39119C5E-A5BF-481C-BB92-9F3153C54696 Q34436523-3B7208E2-958D-4AE5-8827-C695E5CB92AF Q34443454-B89190C3-B832-445C-85F1-55D55202B5B4 Q34449144-22C289FA-E331-45E7-9CCB-C4F17FDC9D91 Q34582222-964B5475-3150-4173-A524-85A637FF601D

P2860

Significant variability in response to inhaled corticosteroids for persistent asthma.

http://www.wikidata.org/entity/Q43920193

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Significant variability in response to inhaled corticosteroids for persistent asthma.

@en

Significant variability in response to inhaled corticosteroids for persistent asthma.

@nl

type

label

Significant variability in response to inhaled corticosteroids for persistent asthma.

@en

Significant variability in response to inhaled corticosteroids for persistent asthma.

@nl

prefLabel

Significant variability in response to inhaled corticosteroids for persistent asthma.

@en

Significant variability in response to inhaled corticosteroids for persistent asthma.

@nl

P1433

Q43920193-017438FC-0139-456A-A63A-9F9DD8F1AD5B

P1476

Q43920193-0BB14EFE-C6E4-4C44-BDB3-EC5ED8A12FA0

P2093

Q43920193-03D138EB-A940-46AF-B927-507BEAE82E62

Q43920193-2799F6E8-AEC8-4CEF-BD5A-CA14F3B76F56

Q43920193-28A89504-D301-413A-BE5E-283F03B8E0B5

Q43920193-299C8958-D634-49BB-B0EC-304A9531610F

Q43920193-2FB6431D-1F79-4509-B1B5-103F2CB67217

Q43920193-39F8C24D-2480-4B7A-889E-F589F53D2A60

Q43920193-3A540BEF-C095-480F-9706-9EA7D595F477

Q43920193-5DD8739B-205C-44A9-9695-A46B3DE814E0

Q43920193-60A1B928-0597-4723-95EF-E3F9EF318A7C

Q43920193-667009D3-BFE4-4093-9BA8-40A34645EF5F

P304

Q43920193-7E6F93AA-C886-40CA-92E4-01969D3CD985

P31

Q43920193-E6EFFA3A-4FF3-45DB-BAE5-AA223D4756E7

P356

Q43920193-A65E2BA3-5F78-40DE-B7AC-8E1D5B96EC88

P407

Q43920193-28147981-913C-49FD-98BC-1F81C57B68C0

P433

Q43920193-971946DD-E364-47A3-AD5D-39B727CA22EF

P478

Q43920193-22C06D20-EC37-4A74-8869-F2CF622D1CF5

P50

Q43920193-A9DA03A2-C6A1-4A60-8E5E-55205CB4BFD6

Q43920193-EEAB488B-FB67-4187-90FE-B6D641817389

Q43920193-F92EBCA8-013C-4C65-AFD9-53D2B43C96CF

P577

Q43920193-DA649794-3D00-432D-AD41-488673CBCF37

P698

Q43920193-3C7EF0EB-7D94-45EE-90D9-82A9ED4C0969

P921

Q43920193-7A75ED03-C569-4051-944B-24DC6AD838C9

P356

MAI.2002.122635

P1433

The Journal of Allergy and Clinical Immunology

P1476

Significant variability in response to inhaled corticosteroids for persistent asthma.

@en

P2093

Asthma Clinical Research Network of the National Heart Lung, and Blood Institute

http://www.w3.org/2001/XMLSchema#string

Christine A Sorkness

http://www.w3.org/2001/XMLSchema#string

Elizabeth Mauger

http://www.w3.org/2001/XMLSchema#string

Elliot Israel

http://www.w3.org/2001/XMLSchema#string

Homer A Boushey

http://www.w3.org/2001/XMLSchema#string

James E Fish

http://www.w3.org/2001/XMLSchema#string

James Kiley

http://www.w3.org/2001/XMLSchema#string

Jean G Ford

http://www.w3.org/2001/XMLSchema#string

Joanne K Fagan

http://www.w3.org/2001/XMLSchema#string

John V Fahy

http://www.w3.org/2001/XMLSchema#string

P304

410-418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1067/MAI.2002.122635

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey M. Drazen

Stanley J Szefler

Robert F Lemanske

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11897984

http://www.w3.org/2001/XMLSchema#string

P921